Metraipolis › archive › dc_f070d108aa4d
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41550694
- DOI
- 10.1093/ofid/ofaf817
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:05:15.015Z
- SHA-256 of the archived text
a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2- Stable URL of this page
https://metraipolis.com/documento/dc_f070d108aa4d
How to cite
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694 — Europe PMC (en), https://europepmc.org/article/MED/41550694 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f070d108aa4d (Metraipolis archive dc_f070d108aa4d, sha256 a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2)
BibTeX
@misc{dcf070d108aa4d,
title = {Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41550694},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f070d108aa4d; sha256 a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41550694. Agents can read the archived copy with the MCP tool read_document.